CANbridge Life Sciences Ltd. is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare products for serious and critical medical conditions in China and North Asia (Korea and Taiwan). CANbridge develops partnerships with Western bio-pharmaceutical companies with clinical-stage pharmaceutical, medical device or diagnostic products that are either unavailable in China/North Asia or address medical needs that are underserved in the region. CANbridge also licenses or obtains exclusive rights to commercialize drug and device products that are approved in their home markets for commercialization in China and North Asia.
- 2016-06-03 CANBRIDGE LIFE SCIENCES LTD. ELECTED TO BE A MEMBER OF PHIRDA
- 2016-05-29 JAMES XUE, FOUNDER AND CEO OF CANBRIDGE, PRESENT AT 2016 BOSTON CEO CONFERENCE
- 2016-04-07 CANBRIDGE SUBMITS INVESTIGATIONAL NEW DRUG APPLICATION TO TAIWAN FOOD AND DRUG ADMINISTRATION FOR CAN-008 PHASE I/II TRIAL IN GLIOBLASTOMA
Addr: Suite 303A, Building E, Wangjing Pioneer Park,
No. 2 LizeZhongEr Road, Chaoyang District, Beijing, China